Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Amortizatization of Intangibles (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $82000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Amortizatization of Intangibles fell 74.77% year-over-year to $82000.0, compared with a TTM value of $788000.0 through Dec 2019, up 17.61%, and an annual FY2024 reading of $5.3 million, up 185.19% over the prior year.
  • Amortizatization of Intangibles was $82000.0 for Q4 2019 at Larimar Therapeutics, down from $160000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $487000.0 in Q4 2015 and bottomed at -$2.0 million in Q4 2016.
  • Average Amortizatization of Intangibles over 5 years is $70900.0, with a median of $189500.0 recorded in 2016.
  • The sharpest move saw Amortizatization of Intangibles crashed 504.72% in 2016, then soared 2472.73% in 2019.
  • Year by year, Amortizatization of Intangibles stood at $487000.0 in 2015, then plummeted by 504.72% to -$2.0 million in 2016, then soared by 98.63% to -$27000.0 in 2017, then soared by 1303.7% to $325000.0 in 2018, then crashed by 74.77% to $82000.0 in 2019.
  • Business Quant data shows Amortizatization of Intangibles for LRMR at $82000.0 in Q4 2019, $160000.0 in Q3 2019, and $263000.0 in Q2 2019.